BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wu DL, Sui FY, Jiang XM, Jiang XH. Methylation in esophageal carcinogenesis. World J Gastroenterol 2006; 12(43): 6933-6940 [PMID: 17109513 DOI: 10.3748/wjg.v12.i43.6933]
URL: https://www.wjgnet.com/1007-9327/full/v12/i43/6933.htm
Number Citing Articles
1
Lawrence R. Kleinberg, Malcolm V. Brock, Sanjay B. Jagannath, Arlene A. Forastiere. Abeloff's Clinical Oncology2008; : 1399 doi: 10.1016/B978-0-443-06694-8.50082-8
2
Lisa Adams, Mark J. Roth, Christian C. Abnet, Sonja P. Dawsey, You-Lin Qiao, Guo-Qing Wang, Wen-Qiang Wei, Ning Lu, Sanford M. Dawsey, Karen Woodson. Promoter Methylation in Cytology Specimens as an Early Detection Marker for Esophageal Squamous Dysplasia and Early Esophageal Squamous Cell CarcinomaCancer Prevention Research 2008; 1(5): 357 doi: 10.1158/1940-6207.CAPR-08-0061
3
Eun Ju Lee, Bo Bin Lee, Joungho Han, Eun Yoon Cho, Young Mog Shim, Joobae Park, Duk‐Hwan Kim. CpG island hypermethylation of E‐cadherin (CDH1) and integrin α4 is associated with recurrence of early stage esophageal squamous cell carcinomaInternational Journal of Cancer 2008; 123(9): 2073 doi: 10.1002/ijc.23598
4
Ramona G. Dumitrescu. Cancer EpidemiologyMethods in Molecular Biology 2009; 471: 457 doi: 10.1007/978-1-59745-416-2_23
5
Joanne P. Young, Peter W. Laird. Genetics of Colorectal Cancer2009; : 73 doi: 10.1007/978-0-387-09568-4_4
6
Hironobu Shigaki, Yoshifumi Baba, Masayuki Watanabe, Shiro Iwagami, Keisuke Miyake, Takatsugu Ishimoto, Masaaki Iwatsuki, Hideo Baba. LINE-1 Hypomethylation in Noncancerous Esophageal Mucosae is Associated with Smoking HistoryAnnals of Surgical Oncology 2012; 19(13): 4238 doi: 10.1245/s10434-012-2488-y
7
Oliver J. Pickering, Stella P. Breininger, Timothy J. Underwood, Zoë S. Walters. Histone Modifying Enzymes as Targets for Therapeutic Intervention in Oesophageal AdenocarcinomaCancers 2021; 13(16): 4084 doi: 10.3390/cancers13164084
8
Chen Chen, Ni Yin, Bangliang Yin, Qianjin Lu. DNA methylation in thoracic neoplasmsCancer Letters 2011; 301(1): 7 doi: 10.1016/j.canlet.2010.10.017
9
Wei Guo, Guiying Wang, Yuran Dong, Yanli Guo, Gang Kuang, Zhiming Dong. Decreased expression of WWOX in the development of esophageal squamous cell carcinomaMolecular Carcinogenesis 2013; 52(4): 265 doi: 10.1002/mc.21853
10
Wei Guo, Zhiming Dong, Xinwen Lin, Minghui Zhang, Gang Kuang, Tienian Zhu. Decreased Expression and Aberrant Methylation of Raf Kinase Inhibitory Protein Gene in Esophageal Squamous Cell CarcinomaCancer Investigation 2012; 30(10): 703 doi: 10.3109/07357907.2012.732164
11
Wang-Kai Fang, Wei Gu, En-Min Li, Zhi-Yong Wu, Zhong-Ying Shen, Jin-Hui Shen, Jian-Yi Wu, Feng Pan, Zhuo Lv, Xiu-E Xu, Qiao Huang, Li-Yan Xu. Reduced membranous and ectopic cytoplasmic expression of DSC2 in esophageal squamous cell carcinoma: an independent prognostic factorHuman Pathology 2010; 41(10): 1456 doi: 10.1016/j.humpath.2010.04.003
12
C. Hennequin, L. Quero, V. Baruch-Hennequin, C. Maylin. Faut-il encore opérer les cancers de l’œsophage localement évolués ?Cancer/Radiothérapie 2008; 12(8): 831 doi: 10.1016/j.canrad.2008.05.005
13
Matthew Koshy, Bruce D. Greenwald, Petr Hausner, Mark J. Krasna, Naomi Horiba, Richard J. Battafarano, Whitney Burrows, Mohan Suntharalingam. Outcomes After Trimodality Therapy for Esophageal CancerAmerican Journal of Clinical Oncology 2011; 34(3): 259 doi: 10.1097/COC.0b013e3181e841ce
14
Javad Mohammadi-Asl. Epigenetics Territory and Cancer2015; : 479 doi: 10.1007/978-94-017-9639-2_15
15
Jurjen J Boonstra, Winand NM Dinjens, Hugo W Tilanus, Linetta B Koppert. Molecular biological challenges in he treatment of esophageal adenocarcinomaExpert Review of Gastroenterology & Hepatology 2007; 1(2): 275 doi: 10.1586/17474124.1.2.275
16
Lawrence Kleinberg, Arlene A. Forastiere. Chemoradiation in the Management of Esophageal CancerJournal of Clinical Oncology 2007; 25(26): 4110 doi: 10.1200/JCO.2007.12.0881
17
Toshiyuki Sakaeda, Motohiro Yamamori, Akiko Kuwahara, Kohshi Nishiguchi. Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapyAdvanced Drug Delivery Reviews 2009; 61(5): 388 doi: 10.1016/j.addr.2008.10.005